Clinical Research Directory
Browse clinical research sites, groups, and studies.
An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
Sponsor: M.D. Anderson Cancer Center
Summary
This trial investigates whether hyperpolarized magnetic resonance imaging (hpMRI) can predict treatment response in patients with thyroid cancer and other malignancies of the head and neck undergoing radiation therapy and/or receiving systemic therapy before surgery. An hpMRI is like a standard MRI but involves the use of an imaging contrast agent called hyperpolarized 13-C-pyruvate. Diagnostic procedures, such as hpMRI, may predict a patient's response to treatment and may help plan the best treatment.
Official title: Pilot Study of Metabolic Guidance for Therapy in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2020-08-12
Completion Date
2027-05-31
Last Updated
2025-11-21
Healthy Volunteers
Yes
Conditions
Interventions
Hyperpolarized Carbon C 13 Pyruvate
Given IV
Magnetic Resonance Imaging
Undergo MRI
Magnetic Resonance Imaging
Undergo hpMRI
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States